Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer

Abstract Th7R is a novel Th1-like CD4+ T cell lineage characterized by TCF7 and IL-7 receptor expression, exhibiting distinct transcriptional and epigenetic profiles compared with classical Th1 cells. The clinical significance of Th7R, including the efficacy of immune checkpoint inhibitors and the p...

詳細記述

書誌詳細

主要な著者:	Shota Takei, Ayako Shiono, Satoshi Yamasaki, Ou Yamaguchi, Atsuto Mouri, Yu Miura, Kosuke Hashimoto, Hisao Imai, Kyoichi Kaira, Hiroshi Kagamu
フォーマット:	Artigo
言語:	Inglês
出版事項:	Springer 2025-12-01
シリーズ:	Cancer Immunology, Immunotherapy
主題:	Th7R CD4+ T cell Small cell lung cancer Immune checkpoint blockade Precursor exhausted T cells (Tpex) Tumor microenvironment
オンライン･アクセス:	https://doi.org/10.1007/s00262-025-04242-6
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!